Humanisierte Antikörper gegen Amyloid beta

Patent europeic · EP2468770 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2468770
Numer da la dumonda
EP11192705
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
13-07-2007
Publitgà
27-06-2012
Concedì
20-12-2017
La protecziun finescha il pli tard
12-07-2027
Proxima taxa annuala scadenta
31-07-2026
Classas IPC
C07K 16/18 (2006.01)
A61P 25/28 (2006.01)
Prioritad
US 94328907 P 11.06.2007
US 94349907 P 12.06.2007
EP 06014730 14.07.2006
EP 06020765 02.10.2006
Derivà da
EP07840408
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2025

    Midada

    Published in Swissreg on 01.08.2025

  2. 01-08-2024

    Midada

    Published in Swissreg on 01.08.2024

  3. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  4. 01-08-2022

    Midada

    Published in Swissreg on 01.08.2022

  5. 20-12-2017

    Concedì

    Published in Swissreg on 20.12.2017

Partidas

Possessur

AC Immune SA

AC Immune S.A.

EPFL Innovation Park Building B, 1015 Lausanne

GENENTECH, INC.

Genentech, Inc.

One DNA Way, South San Francisco, CA 94080-4990, US

Inventur

Pfeifer, Andrea

1806 St.-Légier

Pihlgren Bosch, Maria

1052 Mont-sur-Lausanne

Muhs, Andreas

1053 Cugny

Watts, Ryan

San Mateo, CA 94402, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.